USPTO serial 79248801
INNOPREP
Reviewed by CopyMark Law Group
Reg. 5876650Status 709
- Filing date
- Status date
- Registration date
- Oct 8, 2019
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INNOPREP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; photographic chemicals; chemical compositions for developing photographs; chemicals for use in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; industrial chemicals for the treatment of liquids; chemicals for the treatment of industrial water and wastewater; unprocessed artificial resins; soil fertilizers; fire-extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather, namely, oils for tanning leather; enzymes for use in the tanning of leather; adhesives for use in industry; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of cosmetics; chromatography chemicals; chromatography chemicals for the separation of liquids | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, medical and veterinary preparations all for the prevention and treatment of cardiovascular, autoimmune and inflammatory, neurodegenerative, respiratory, and metabolic disorders and diseases; pharmaceutical, medical and veterinary preparations all for the prevention and treatment of diabetes, osteoporosis, and cancer; sanitary sterilizing preparations for medical purposes; sanitary preparations for medical use; dietetic sugar for medical use; dietetic foods adapted for medical purposes; dietetic beverages adapted for veterinary use; dietetic infusions for medical use; dietetic foods, namely crackers for medical use; dietetic foods for treating gastrointestinal disorders and diabetes for medical and veterinary use; food for babies; food supplements for humans and animals; medical plasters; medical dressings; wound dressings; burn dressings; gauze for dressings; self-adhesive dressings; material for dental fillings and dental impressions; disinfectants; natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; probiotic supplements; probiotic preparations for medical use; dietary fiber to aid digestion; dietary fiber for treating constipation; dietary fiber for use as an ingredient in the manufacture of dietary supplements; stem cells for medical or veterinary use; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; medicaments to help assist with the regeneration of ligament and tendon fibers; enzymes for medical and veterinary use; phototherapy preparations for medical use | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; scientific and technological services, namely, research and design in the field of computer networking hardware, computer datacenter architecture; technology research in the field of medical instruments; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for scientific and technological applications; scientific research and development; DNA analysis services for scientific research purposes; scientific research for medical purposes in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; scientific research in the field of genetics and genetic engineering; industrial research in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders and scientific analysis related thereto; design and development of computer hardware and software; research, development and design of computer software for use in medical diagnosis and disease analysis; scientific research in the nature of conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; scientific laboratory services; scientific study and research projects in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; engineering; energy auditing; scientific and technological research in the field of chromatography; research in the field of chemistry ; chemistry consultation; product testing; pharmaceutical product evaluation and testing; product quality evaluation; laboratory research and analysis in the field of chromatography; consulting services in the field of design and development of engineering processes for the transformation and purification of liquids, molecules and raw materials for others; consulting services in the field of cloud computing; providing virtual computer systems and virtual computer environments through cloud computing; rental of computer software; updating of software; programming for computers; research and development of new products for others; electronic data storage; providing a web hosting platform for scientific and medical research in the fields of the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; web site hosting services; providing temporary use of on-line non-downloadable software for use in database management accessible via an Internet website; designing Internet websites for others in the field of shared document collaboration; engineering services relating to robotics; development of software for patients; chemical engineering; materials testing | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named INNOPREP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2026 | C71T | CANCELLED SECTION 71 | — |
| Oct 8, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 21, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 3, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 3, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 8, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 8, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 23, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 23, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 19, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 19, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 19, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 19, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 7, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 8, 2019 | RFNP | REFUSAL PROCESSED BY IB | — |
| Feb 20, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 19, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 23, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 22, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 3, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |